Cellebrite DI Ltd.·4

May 26, 4:06 PM ET

GEE DAVID NICHOLAS 4

Research Summary

AI-generated summary

Updated

Cellebrite (CLBT) CMO David Gee Sells Shares

What Happened
David Gee, Chief Marketing Officer of Cellebrite DI Ltd. (CLBT), sold a total of 5,673 shares on May 21, 2026. The sales consisted of 2,243 shares at $13.10 ($29,383) and 3,430 shares at $13.15 ($45,094), totaling approximately $74,477 (weighted average ≈ $13.12/share). These shares were dispositions of RSUs granted May 20, 2024, and the sale was associated with tax obligations from vesting.

Key Details

  • Transaction date: May 21, 2026; Form 4 filed May 26, 2026 (reporting period: May 21, 2026).
  • Shares sold: 5,673 total (2,243 @ $13.10 and 3,430 @ $13.15). Total proceeds ≈ $74,477.
  • Footnotes: Sales relate to RSUs granted May 20, 2024 (tax withholding), and were effected under a Rule 10b5-1 trading plan adopted Nov 18, 2025.
  • Price ranges: reported weighted averages; individual sales occurred across price ranges of $12.98–$13.32 and $13.00–$13.30 (reporting person can provide lot-level breakdown on request).
  • Shares owned after the transaction: not specified in the provided excerpt.
  • Filing timeliness: Form filed within days after the transaction (no late-filing flag provided).

Context
These were routine sell-to-cover transactions of vested RSUs executed under a pre-established 10b5-1 plan, which is commonly used to automate taxes or diversification needs and reduces concerns about trade timing. Sales of vested equity for tax purposes are not the same signal as voluntary market-timed selling; investors should watch future insider filings for meaningful changes in ownership.